Dr. Goldin was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Institute of Allergy and Infectious Diseases, July 2019 - 2025.

Prior to joining the program, Dr. Goldin received her D.V.M. in May of 2019 from the University of Minnesota.  She has completed her diagnostic pathology training and the university portion of her research at Michigan State University, East Lansing, Michigan. In July of 2021, she started the laboratory portion of her research at Rocky Mountain Laboratory within the Laboratory of Virology Molecular Pathogenesis Unit. Dr. Goldin’s research interests lie in the area of infectious disease and comparative pathobiology.  Specifically, the study of emerging viral pathogens, pathogenesis of dormancy and reactivation of these emerging viral antigens, and animal disease modeling. Dr. Goldin received her PhD in June 2025.

Dr. Davis is a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Purdue University and the National Institute of Allergy and Infectious Diseases, July 2019 – present.

Prior to joining the program, Dr. Davis received her DVM in May of 2019 from the Ohio State University where she first gained interest in allergic disease research.  Dr. Davis is interested in how genetically modified mouse models of allergies can be utilized to unravel the complex mechanisms driving allergic response and assist in the development of new immunomodulatory treatments.